Spectral CT Combined with Tumor Markers to Predict Ki-67 Expression in Lung Adenocarcinoma

Purpose: To investigate the predictive value of energy spectrum CT quantitative parameters combined with serum tumor markers (CEA, CA-125) on Ki-67 expression in lung adenocarcinoma. Methods: The clinicopathological and imaging data of 64 patients with lung adenocarcinoma confirmed by pathology from...

Full description

Bibliographic Details
Published in:	CT Lilun yu yingyong yanjiu
Main Authors:	Peipei DOU, Hengliang ZHAO, Aihong CAO
Format:	Article
Language:	English
Published:	Editorial Office of Computerized Tomography Theory and Application 2023-11-01
Subjects:	energy spectrum ct lung adenocarcinoma tumor markers ki-67
Online Access:	https://www.cttacn.org.cn/cn/article/doi/10.15953/j.ctta.2022.172

Similar Items

Prediction of Ki-67 Expression in HIV-Associated Lung Adenocarcinoma Patients Using Multiple Machine Learning Models Based on CT Imaging Radiomics
by: Song C, et al.
Published: (2025-04-01)

Proliferation Marker (Ki67) in Sub-Categorization of Neuroendocrine Tumours of the Lung
by: Rashi GARG, et al.
Published: (2019-01-01)

RELATIONSHIP BETWEEN ARGYROPHILIC PROTEINS OF NUCLEOLAR ORGANIZER REGIONS AND ANTIGEN KI-67 WITH CLINICAL AND MORPHOLOGICAL PARAMETERS AND SURVIVAL IN LUNG ADENOCARCINOMA
by: D. S. Kobyakov, et al.
Published: (2016-02-01)

Relationships between growth rate and Ki-67 and immune indices in ground-glass nodule-featured lung adenocarcinoma
by: Yifan He, et al.
Published: (2025-09-01)

CT-based radiomics for predicting Ki-67 expression in lung cancer: a systematic review and meta-analysis
by: Xinmin Luo, et al.
Published: (2024-02-01)

Nomogram for the preoperative prediction of Ki-67 expression and prognosis in stage IA lung adenocarcinoma based on clinical and multi-slice spiral computed tomography features
by: Zhengteng Li, et al.
Published: (2024-06-01)

The Correlation Between the Natural Course, Pathologic Properties With Ki‐67 Expression in Lung Adenocarcinoma Presenting as Ground‐Glass Nodules
by: Shaohui Huang, et al.
Published: (2024-11-01)

Investigation of Ki-67 and Clinical Outcome in Feline Nasal Adenocarcinoma Treated Using Hypofractionated Radiotherapy
by: Premkamon Aonta, et al.
Published: (2024-12-01)

Expression of CDX-2 and Ki-67 in different grades of colorectal adenocarcinomas
by: Anway Sen, et al.
Published: (2015-01-01)

Analysis of tumor cell proliferation (Ki-67) and cell cycle regulator proteins in lung adenocarcinoma with different radiological subtypes
by: Rirong Qu, et al.
Published: (2025-04-01)

Expression and Clinical Significance of Heparanase and Ki-67 in Non-small Cell Lung Cancer
by: Xiaoming QIU, et al.
Published: (2009-07-01)

Development and verification of a radiomics model to forecast Ki67 index and prognosis in advanced gastric tubular adenocarcinoma
by: Jiatong Lu, et al.
Published: (2025-04-01)

Prognostic Value of Ki67 and Other Clinical and Histopathological Factors in Canine Apocrine Gland Anal Sac Adenocarcinoma
by: Emanuela Maria Morello, et al.
Published: (2021-06-01)

The importance of Ki-67 proliferation index in small cell lung cancer
by: Seda Beyhan Sağmen, et al.
Published: (2025-01-01)

Prognostic significance of grade of malignancy based on histopathological differentiation and Ki-67 in pancreatic ductal adenocarcinoma
by: Yuexiang Liang, et al.
Published: (2024-05-01)

Prediction of Ki-67 expression in bladder cancer based on CT radiomics nomogram
by: Shengxing Feng, et al.
Published: (2024-02-01)

Radiomics analysis of dual-layer detector spectral CT-derived iodine maps for predicting Ki-67 PI in pancreatic ductal adenocarcinoma
by: Dan Zeng, et al.
Published: (2025-04-01)

Histopathological Study of Gastric Adenocarcinoma with Special Reference to Expression of HER2/neu and Ki-67 Assessed by Immunohistochemistry
by: Saiqa Nisar, et al.
Published: (2024-10-01)

Cutaneous Canine Mast Cell Tumor: The Use of Proliferative Markers (Ki-67 and Ki-67 × AgNOR) in Cytological Samples for Diagnosis and Prognosis
by: Christina Marouda, et al.
Published: (2024-01-01)

Ki67 index importance in patients with breast cancer
by: O. Bondar
Published: (2024-12-01)

A correlation research of Ki67 index, CT features, and risk stratification in gastrointestinal stromal tumor
by: Huali Li, et al.
Published: (2018-09-01)

Combined utility of Ki-67 index and tumor grade to stratify patients with pancreatic ductal adenocarcinoma who underwent upfront surgery
by: Bo Li, et al.
Published: (2023-12-01)

Imaging characteristics of central neurocytomas according to Ki-67 proliferation index
by: Yan-li Zhang, et al.
Published: (2025-06-01)

Neoplasias astrocitárias e correlação com as proteínas p53 mutada e Ki-67 Astrocytic neoplasms and correlation with mutate p53 and Ki-67 proteins
by: Gustavo Rassier Isolan, et al.
Published: (2005-12-01)

Diagnostic Efficacy of CT Examination on Early Detection of Lung Cancer during Pandemic of COVID-19
by: Yanjie Zhao, et al.
Published: (2022-09-01)

The impact of stratified management of Ki-67 on the prognosis of small-cell lung cancer
by: Xiaofang Zhang, et al.
Published: (2025-07-01)

The correlation between EGFR mutation status and clinicopathological characteristics, Ki67 expression and immune cell infiltration in lung adenocarcinoma with different radiological subtypes
by: Rirong Qu, et al.
Published: (2025-08-01)

Expression of Ki 67 and P53 immunohistochemical markers in central nervous system astrocytoma
by: Mahmood Sh. Mahmood, et al.
Published: (2015-01-01)

Gene experison of cell proliferative marker Ki67 in breast cancer
by: Golmohammadi R (PhD), et al.
Published: (2011-09-01)

Evaluation of salivary Ki-67 in health and periodontitis
by: Mohamed Abdalla Ali Ahmed, et al.
Published: (2025-03-01)

Study of morphology with assessment of expression of proliferation marker Ki67 antigen and P53 protein in lesions of gall bladder
by: Ojasvi Ramesh, et al.
Published: (2024-04-01)

Combining clinical characteristics with CT radiomics to predict Ki67 expression level of small renal mass based on artificial intelligence algorithms
by: Junyi Lin, et al.
Published: (2025-02-01)

The cell proliferation antigen Ki-67 organises heterochromatin
by: Michal Sobecki, et al.
Published: (2016-03-01)

Evaluation of the proliferation marker Ki67 as a prognostic factor in patients with breast carcinoma
by: Fatima S. Al-Sarraf, et al.
Published: (2015-07-01)

Correlation of 18F-fluorodeoxyglucose positron emission tomography/computed tomography related parameters with the degree of proliferation in lung adenocarcinoma
by: Jian-gong Shi, et al.
Published: (2025-07-01)

Blood biomarkers and Ki-67 proliferation marker in breast cancer
by: A. A. Studenikina, et al.
Published: (2023-04-01)

Utility of Serum Ki-67 as a Marker for Malignancy in Dogs
by: Annkathrin Estaller, et al.
Published: (2022-05-01)

Relationship Between SUVmax and Ki-67 Expression in Breast Cancer
by: Meriç Emre Bostancı, et al.
Published: (2020-09-01)

NUCLEAR ORGANIZERS IN KI-67 POSITIVE CELLS OF SQUAMOUS CELL LUNG CANCER: CLINICAL MORPHOLOGICAL PARALLELS AND SURVIVAL
by: D. S. Kobyakov, et al.
Published: (2016-02-01)

Immunohistochemical markers: carcinoembryonic antigen, p53, Ki-67, and proliferating cell nuclear antigen as prognostic factors for colorectal cancer
by: Siniša Maksimović, et al.
Published: (2018-07-01)